Loading...

In Silico Evaluation of an Artificial Pancreas Combining Exogenous Ultrafast-Acting Technosphere Insulin with Zone Model Predictive Control

BACKGROUND: Because of the slow pharmacokinetics of subcutaneous (SC) insulin, avoiding postprandial hyperglycemia has been a major challenge for an artificial pancreas (AP) using SC insulin without a meal announcement. METHODS: A semiautomated AP with Technosphere® Insulin (TI; MannKind Corporation...

Full description

Saved in:
Bibliographic Details
Main Authors: Lee, Justin J., Dassau, Eyal, Zisser, Howard, Harvey, Rebecca A., Jovanovič, Lois, Doyle, Francis J.
Format: Artigo
Language:Inglês
Published: Diabetes Technology Society 2013
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3692236/
https://ncbi.nlm.nih.gov/pubmed/23439180
Tags: Add Tag
No Tags, Be the first to tag this record!